Admission, drugs, and mortality of patients with COVID-19 in different risk groups
| Low risk n=289 | Intermediate risk n=141 | High risk n=66 | Very high risk n=10 | P value | ||
| Admission | Home | 232 (84.1) | 34 (23.1) | 7 (9.6) | 0 (0) | <0.001 |
| Hospital | 44 (15.9) | 101 (68.7) | 45 (61.6) | 1 (10) | <0.001 | |
| ICU | 0 (0.0) | 12 (8.2) | 21 (28.8) | 9 (90) | <0.001 | |
| NIV/MV | NIV | 1 (0.3) | 13 (9.2) | 10 (15.2) | 0 (0) | <0.001 |
| MV | 0 (0.0) | 8 (5.7) | 17 (25.8) | 9 (90) | <0.001 | |
| Both | 0 (0.0) | 3 (2.1) | 0 (0) | 0 (0) | <0.001 | |
| Hydroxychloroquine | 269 (93.1) | 88 (62.4) | 35 (53) | 1 (10) | <0.001 | |
| Lopinavir/ritonavir | 11 (3.8) | 45 (31.9) | 23 (34.8) | 9 (90) | <0.001 | |
| Ribavirin | 3 (1) | 21 (14.9) | 23 (34.8) | 9 (90) | <0.001 | |
| Dexamethasone | 11 (3.8) | 38 (27.1) | 34 (51.5) | 8 (80) | <0.001 | |
| Interferon-beta 1b | 1 (0.4) | 8 (5.7) | 6 (9.1) | 1 (10) | <0.001 | |
| Anticoagulant | 27 (9.4) | 71 (51.8) | 53 (81.5) | 10 (100) | <0.001 | |
| Actual mortality | 0 (0) | 9 (6.4) | 13 (19.7) | 9 (90) | <0.001 | |
| Estimated mortality | 1.2% | 9.9% | 31.4% | 61.5% | <0.001 | |
ICU, intensive care unit; MV, mechanical ventilation; NIV, non-invasive ventilation.